Kolexia
Vassal Gilles
Pédiatrie
Gustave-Roussy
Villejuif, France
336 Activités
350 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Neuroblastome Gliome Récidive tumorale locale Tumeurs du cerveau Tumeurs du poumon Tumeurs osseuses Sarcome d'Ewing Sarcomes Lymphomes

Industries

MSD
2 collaboration(s)
Dernière en 2023
BMS
1 collaboration(s)
Dernière en 2020
Bayer
1 collaboration(s)
Dernière en 2022
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy: A Multi-center, Open-label, Non-randomized, Phase I Dose Escalation Study of Regorafenib (BAY 73-4506) in Pediatric Subjects With Solid Malignant Tumors That Are Recurrent or Refractory to Standard Therapy
Essai Clinique (Bayer)   18 mars 2024
ON-TRK: PrOspective Non-interventional Study in Patients With Locally Advanced or Metastatic TRK Fusion Cancer Treated With Larotrectinib
Essai Clinique (Bayer)   29 février 2024
AcSé CRIZOTINIB : Secured Access to Crizotinib for Patients With Tumors Harboring a Genomic Alteration on One of the Biological Targets of the Drug.
Essai Clinique (Unicancer)   26 février 2024
Clinical trial inclusion in patients with relapsed/refractory neuroblastoma following the European Precision Cancer Medicine trial MAPPYACTS.
European journal of cancer (Oxford, England : 1990)   15 février 2024
The organization of care in pediatric radiotherapy across SIOP Europe affiliated centers: A multicenter survey in the framework of the 'Joint Action on Rare Cancers' project.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   28 décembre 2023
Phase I/II study of the WEE1 inhibitor adavosertib (AZD1775) in combination with carboplatin in children with advanced malignancies: Arm C of the AcSé-ESMART trial.
Clinical cancer research : an official journal of the American Association for Cancer Research   05 décembre 2023
Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   27 novembre 2023
Solutions for optimal care and research for children and adolescents with extremely rare cancers developed within the Joint Action for Rare Cancers (JARC)
EJC paediatric oncology   22 novembre 2023
Impact of ACCELERATE Paediatric Strategy Forums: A review of the value of multi-stakeholder meetings in oncology drug development.
Journal of the National Cancer Institute   17 novembre 2023
Rescuing drugs that are discontinued in adult oncology development for the benefit of children and adolescents with cancer - An ACCELERATE multi-stakeholder consensus.
Clinical pharmacology and therapeutics   27 octobre 2023